GSA Capital Partners’s RxSight RXST Stock Holding History

GSA Capital Partners’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$335K	Sell	54,453 -32,267	-37%	-$268K	0.02%	1185
2025 Q4	$904K	Buy	86,720 +14,205	+20%	+$143K	0.08%	425
2025 Q3	$652K	Buy	72,515 +4,743	+7%	+$41.6K	0.05%	674
2025 Q2	$881K	Buy	67,772 +29,316	+76%	+$441K	0.06%	541
2025 Q1	$971K	Buy	38,456 +13,892	+57%	+$413K	0.09%	361
2024 Q4	$845K	Buy	24,564 +3,480	+17%	+$157K	0.06%	523
2024 Q3	$1.04M	Sell	21,084 -14,772	-41%	-$757K	0.08%	444
2024 Q2	$2.16M	Sell	35,856 -1,533	-4%	-$87.6K	0.15%	121
2024 Q1	$1.93M	Buy	+37,389	New	+$1.84M	0.15%	135
2023 Q4	–	Sell	-22,532	Closed	-$628K	–	1867
2023 Q3	$628K	Sell	22,532 -10,650	-32%	-$318K	0.05%	654
2023 Q2	$956K	Buy	+33,182	New	+$738K	0.1%	335

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

GSA Capital Partners's RXST Position: Q1 2026 in Review

GSA Capital Partners reduced its RxSight (RXST) stake by 37% in Q1 2026, selling an estimated $268K and leaving 54,453 shares worth $335K. The position accounts for 0.02% of the portfolio, ranked #1185.

GSA Capital Partners first reported a position in RXST in Q2 2023 and has held it in 11 quarters since. The position peaked at $2.16M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

GSA Capital Partners held 54,453 shares of RxSight worth $335K as of Q1 2026.
GSA Capital Partners sold 32,267 RxSight shares in Q1 2026, an estimated $268K.
RxSight made up 0.02% of GSA Capital Partners's portfolio in Q1 2026, its #1185 holding.
GSA Capital Partners first reported a position in RxSight in Q2 2023 and has held it in 11 quarters since.
GSA Capital Partners's RxSight position peaked at $2.16M in Q2 2024.
164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.